Christopher Chad Shelton

Title: Christopher Chad Shelton: Innovator in Cancer Research

Introduction

Christopher Chad Shelton is a notable inventor based in Alexandria, VA (US). He has made significant contributions to the field of cancer research through his innovative work on polypeptide substrates and their applications in high throughput assay methods.

Latest Patents

Shelton holds a patent for his invention titled "γ-Secretase substrates and methods of use." This patent involves polypeptide substrates based on modifications or fragments of various APP isoforms. The assay methods and screening methods he developed are designed for use in high throughput multi-well plate assay apparatuses. His substrates are often labeled for ease of detection and may bind specific ligands that are also labeled. These features enhance the specificity and sensitivity of detection, making his methods particularly suited for high throughput formats. Additionally, his work identifies small polypeptides based on a subsequence motif of Aβ that are potent inhibitors of γ-secretase activity.

Career Highlights

Christopher Chad Shelton is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to advance his research in cancer treatment methodologies. His work has garnered attention for its potential impact on therapeutic strategies.

Collaborations

Shelton collaborates with esteemed colleagues, including Yuan Tian and Yueming Li, who contribute to his research efforts and enhance the scope of his projects.

Conclusion

Christopher Chad Shelton's innovative contributions to cancer research through his patented methods and collaborative efforts highlight his role as a key figure in the scientific community. His work continues to pave the way for advancements in cancer treatment methodologies.